Phase 2 validation of AFP, DCP and AFP-L3 in early stage hepatocellular carcinoma

被引：0
|
作者：
Marrero, Jorge A.
Llovet, Josep M.
Nguyen, Mindie
Befeler, Alex
Roberts, Lewis R.
Reddy, Rajender R.
Harnois, Denise
Normolle, Daniel
Hui, Ying
Dalhgren, Jackie
Chia, David
Lok, Anna S.
Wagner, Paul D.
Feng, Ziding
Schwartz, Myron
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Mt Sinai Univ, New York, NY USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Penn, Mayo Clin, Jacksonville, FL USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] NCI, Bethesda, MD 20892 USA
来源：
CANCER BIOMARKERS | 2008年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
    Best, J.
    Bilgi, H.
    Heider, D.
    Schotten, C.
    Manka, P.
    Bedreli, S.
    Gorray, M.
    Ertle, J.
    van Grunsven, L. A.
    Dechene, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (12): : 1296 - 1305
  • [2] Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
    Hiraoka, Atsushi
    Ishimaru, Yoshihiro
    Kawasaki, Hideki
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Toshimori, Akiko
    Kawamura, Tomoe
    Yamago, Hiroka
    Nakahara, Hiromasa
    Suga, Yoshifumi
    Azemoto, Nobuaki
    Miyata, Hideki
    Miyamoto, Yasunao
    Ninomiya, Tomoyuki
    Hirooka, Masashi
    Abe, Masanori
    Matsuura, Bunzo
    Hiasa, Yoichi
    Michitaka, Kojiro
    ONCOLOGY, 2015, 89 (03) : 167 - 174
  • [3] Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
    Wang, Xueying
    Zhang, Yangyu
    Yang, Na
    He, Hua
    Tao, Xuerong
    Kou, Changgui
    Jiang, Jing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [4] AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation
    Norman, Joshua S.
    Li, P. Jonathan
    Kotwani, Prashant
    Shui, Amy M.
    Yao, Francis
    Mehta, Neil
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1469 - 1477
  • [5] Utility of four tumor markers, alone and in combination, for detection of hepatocellular carcinoma: AFP, AFP-L3, DCP, and Cystatin
    Li, H.
    Sferruzza, A.
    Qu, K. Z.
    Afdhal, N. H.
    Lai, M.
    Radcliff, J. S.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] CIRCULATING TUMOR DNA (CTDNA) METHYLATION PROFILE IMPROVES THE ACCURACY OF SERUM BIOMARKERS (AFP, AFP-L3, AND DCP) FOR THE DETECTION OF EARLY-STAGE HEPATOCELLULAR CARCINOMA
    Tran, Le Son
    Phan, Minh Duy
    Nguyen, Hoai Nghia
    Phan, Hai Thanh
    Nguyen, Van Thien Chi
    Pham, Thuy
    Nguyen, Van Chu
    Ho, Dat Tan
    Pham, Thi Mong Quynh
    Tran, Thanh Huong Thi
    Nguyen, Thanh Dat
    Le, Nguyen Duy Khang
    Nguyen, Trong Hieu
    Duong, Minh Long
    Bach, Hoai Phuong Thi
    Kim, Van Vu
    Pham, The Anh
    Toan, Nguyen Bao
    Nguyen, Thanh Nhan Vo
    Nguyen, Thanh Dang
    Phu, Dung Thai Bieu
    Phan, Boi Hoan Huu
    Nguyen, Duy Sinh
    Truong, Dinh Kiet
    Do, Thanh Thuy Thi
    Giang, Hoa
    HEPATOLOGY, 2022, 76 : S1304 - S1305
  • [7] Clinical utility of AFP-L3% in early detection of hepatocellular carcinoma
    Wang, YY
    Satomura, S
    Wise, M
    Kanke, F
    Mallory, T
    Schwartz, ME
    Sterling, RK
    Jeffers, L
    Gordon, F
    Reddy, RK
    Venook, AP
    Sherman, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S122 - S122
  • [8] Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
    Ren, Tianying
    Hou, Xu
    Zhang, Xin
    Chen, Dongliang
    Li, Juan
    Zhu, Yingnan
    Liu, Zhiheng
    Yang, Dawei
    HELIYON, 2023, 9 (11)
  • [9] AFP-L3 for the diagnosis of early hepatocellular carcinoma A meta-analysis
    Zhou, Jian-Ming
    Wang, Ting
    Zhang, Kun-He
    MEDICINE, 2021, 100 (43) : E27673
  • [10] AFP-L3% as a biomarker for early recognition of rapidly growing hepatocellular carcinoma
    Wang, Y
    Satomura, S
    Wise, M
    Kanke, F
    Mallory, T
    Schwartz, M
    Sterling, R
    Jeffers, L
    Gordon, F
    Reddy, R
    Venook, AP
    Sherman, M
    HEPATOLOGY, 2005, 42 (04) : 390A - 390A
12345